Status:
RECRUITING
Pharmacist-led Continuous Glucose Monitoring
Lead Sponsor:
University of South Florida
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with ty...
Eligibility Criteria
Inclusion
- type 2 diabetes
- hemoglobin A1c ≥ 8%
- compatible smartphone with FreeStyle Libre 2 continuous glucose monitoring system
- current use and access to a glucometer for self-monitoring of blood glucose
Exclusion
- any continuous glucose monitor use within 6 months prior to study enrollment
- pregnant and planning to become pregnant during study time frame
- history of hypoglycemia requiring third party assistance
- history of diabetic ketoacidosis or hyperosmolar hyperglycemic state within 6 months prior to study enrollment
- known allergy to medical grade adhesives
- current use of systemic steroids for any medical condition
- current use of dialysis
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 5 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06572306
Start Date
September 1 2024
End Date
August 5 2025
Last Update
August 28 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
USF Health Department of Family Medicine - Morsani Center for Advanced Health Care
Tampa, Florida, United States, 33612
2
USF Health Department of Family Medicine - University Partnership Center
Tampa, Florida, United States, 33613